This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08069/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB08069/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08069/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08069/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08069/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08069
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB08069 n13:DB08069
dcterms:title
4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE
adms:identifier
n6:1796123 n7:2405215 n8:99444540 n11:DB08069 n12:L13
n3:IUPAC-Name
n4:271B5B08-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5B0E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5B0D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5B0A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5B0B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5B0C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5B06-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5B04-363D-11E5-9242-09173F13E4C5 n4:271B5B07-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5B05-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5B14-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5B15-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5B0F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5B10-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5B12-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5B11-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5B13-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5B1A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5B1C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5B1D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5B19-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5B18-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5B1B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5B09-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5B16-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5B17-363D-11E5-9242-09173F13E4C5